SCHEMBL3347796

SCHEMBL3347796

Cn1nc2ccc[c]c2c1C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.33
TERT O14746 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ELANE P08246 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
LCK P06239 1/20 0.31
MAP2K3 P46734 1/20 0.31
MAP2K6 P52564 1/20 0.31
BTK Q06187 1/20 0.31
MAP3K19 Q56UN5 1/20 0.31
NEK10 Q6ZWH5 1/20 0.31
GRM2 Q14416 1/20 0.31
PLA2G10 O15496 1/20 0.31
PARP1 P09874 1/20 0.31
KDM5A P29375 1/20 0.30
KDM4C Q9H3R0 1/20 0.30
KDM5B Q9UGL1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3624132 0.80 MGLL (0.33) SMN1; SMN2KDM5AKDM4CKDM5B
SCHEMBL2723759 0.77 LCK (0.41) POLBTERTKDM4EELANELCK
SCHEMBL3659292 0.73 KDM4E (0.39) POLBSMN1; SMN2KDM4EELANEPARP1
SCHEMBL3341086 0.72 SMN1; SMN2 (0.32) POLBTERTSMN1; SMN2KDM4EPIM3
SCHEMBL3344379 0.72 SMN1; SMN2 (0.32) POLBTERTSMN1; SMN2PIM3PIM2
SCHEMBL3372904 0.67 ALDH1A1 (0.31) SMN1; SMN2PIM3PIM2
SCHEMBL3340507 0.66 LCK (0.34) LCKMAP2K3MAP2K6BTKMAP3K19
SCHEMBL1563562 0.65 KDM5A (0.48) SMN1; SMN2KDM4EKDM5AKDM4CKDM5B
SCHEMBL17324739 0.65 KDM5A (0.42) KDM4EKDM5AKDM4CKDM5B
SCHEMBL23367117 0.64 KDM5A (0.41) SMN1; SMN2KDM4EKDM5AKDM4CKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461159-B2 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase Jannsen Pharmaceutica BV (BE) 2013-06-11 US claimed
WO-2010068453-A1 HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA NV (BE) 2010-06-17 WO claimed
US-8877769-B2 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase JANSEEN PHARMACEUTICA NV (BG) 2014-11-04 US disclosed
US-20130245022-A1 HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA NV (US) 2013-09-19 US disclosed
US-8461159-B2 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase Jannsen Pharmaceutica BV (BE) 2013-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245022-A1 HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, GPR119 POLB 1725/4885TERT 4564/4885SMN1; SMN2 1719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.